期刊文献+

食管鳞癌组织AIB1与Ki-67表达相关性研究 被引量:1

Roles for AIB1 protein in proliferation and transformation of human esophageal squamous cell carcinoma
原文传递
导出
摘要 目的:探讨食管鳞癌组织AIB1的表达水平及其与Ki-67的相关性。方法:用免疫组织化学SP方法,联合检测20例正常食管鳞状上皮组织和60例食管鳞癌组织中AIB1和Ki-67的表达,分析AIB1的表达与临床病理参数的关系以及与Ki-67的相关性。结果:20例正常食管鳞状上皮组织中呈微弱表达或不表达,60例食管鳞癌组织中有25例(41.6%)为AIB1高表达,P<0.05。AIB1的表达水平与临床分期、淋巴结转移有明显相关性;在T3~T4期的表达水平高于T1~T2期(P<0.05),在有淋巴结转移的组织中表达较高(P<0.05),而其在不同性别、年龄、病理学分型中的表达差异无统计学意义,P>0.05;Ki-67蛋白在食管鳞状细胞癌中的表达为65.0%(39/60),在39例Ki-67蛋白阳性表达的食管鳞癌组织中有29例同时表达AIB1,且其中25例AIB1过表达,AIB1与Ki-67的表达呈中度正相关,P<0.01。结论:AIB1蛋白与食管鳞癌的临床分期和淋巴结转移有相关性,Ki-67可能也是AIB1蛋白非类固醇激素受体途径的相关蛋白之一。 OBJECTIVE:To investigate the expression of AIB1 in human esophageal squamous cell carcinoma and its correlation with expression of Ki-67. METHODS: The immunohistochemical method SP was used to analyze the expression and clinical significance of AIB1 and Ki-67 in 60 cases of esophageal squamous cell carcinoma,20 cases of control group (the normal esophageal organization),and analyze the correlation between as well as the two relations. RESULTS: In 20 cases of normal esophageal mucosa cells the high expression of AIB1 were the normal level (located in the nucleus, faint expression or not expressed) , but in esophageal squamous cell carcinoma the high expression of AIB1 were 41.6% (P〈 0.05). Moreover,overexpression of AIB1 was observed more frequently in esophageal squamous cell carcinoma with late T stages (T3/T~) and lymph node metastases, P^0.05. There was not significant difference in the positive expression of AIB1 among gender,age and pathological type (P^0.05) ;Ki-67 was expressed in 65.0%(39/60) of patients with esoph- ageal squamous cell carcinoma, P^0. 05. Ki-67 was expressed in 39 cases in the esophageal squamous cell carcinoma group,among which AIB1 was expressed in 29 cases. The expression of AIB1 was positively correlated with that of Ki-67 (P〈0.01). CONCLUSIONS: AIB1 protein expression was associated with the T stage and lymph node metastase. Ki-67 may play a role in AIB1 through nonsteroid receptor pathway.
作者 李苓 王祥阁
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第18期1389-1392,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 食管肿瘤 AIB1 KI-67 esophageal neoplasms AIB1 Ki-67
  • 相关文献

参考文献13

  • 1Lahusen T, Henke RT,Kagan BL, et al. The role and regulation of the nuclear receptor coactivator AIB-1 in breast cancer[J]. Breast Cancer Res Treat,2009,116(2):225- 237.
  • 2Torres-Arzayus MI, Zhao J, Bronson R, et al. Estrogen depend- ent and estrogen-independent mechanisms contribute to AIB-1 mediated tumor formation[J]. Cancer Res, 2010,70(10) : 4102 -4111.
  • 3Alkner S,Bendahl PO,Grabau D,et al. AIB-1 is a predicitive fac tot for tamoxifen response in premenopausal women[J]. Ann Oncol,2010,21(2) :238-244.
  • 4Zhao W,Zhang Q,Kang X,et al. AIB1 is required for the acquisi- tion of epithelial growth factor receptor-mediated tamoxifen re- sistance in breast cancer cells[J]. Bioehem Biophys Res Com- mun,2009,380(3) :699 -704.
  • 5孙爱民,李道堂,穆殿斌,李辉,罗景玉.食管鳞癌组织Cyclin D1和Ki-67表达及其与预后相关性的研究[J].中华肿瘤防治杂志,2008,15(4):276-279. 被引量:11
  • 6Gentile V,Vicini P,Giacomelli L,et al. Detection of human papil- lomavirus DNA, p53 and Ki-67 expression inpenile carcinomas[J].Int J Immunopathol Phamacol, 2006,19 (1) : 209-215.
  • 7Jalava P,Kuopio T,Juntti Patinen L, et al. Ki-67 immunohjsto- chemistry :a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki- 67 immunoreaetivity and standardized mitotic index[J].Histopa thology, 2006,48(6) : 674-682.
  • 8Kirkegaard T, McGlynn LM, Campbell FM, et al. Amplified in breast cancer 1 in human epidermal growth factor receptor-posi tire tumors of tamoxifen-treated breast cancer patients[J]. Clin Cancer Res,2007,13(5) :1405-1411.
  • 9Kuang SQ, Liao L, Wang S, et al. M ice lacking the amplified in cancer steroid receptor co activator-3 are resistant to chemical carcinogen-induced mammary tumor genesis[J]. Cancers, 2008, 65(17) :7993- 8002.
  • 10Sun P, Gao J, Liu YL, et al. RNA interference ( RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction inter feres with lymphangiogenesis and enhances Epirubicin sensitivity of breast cancer cells[J]. Mol Cell Biochem, 2008,308 (1-2) : 161- 168.

二级参考文献28

共引文献10

同被引文献17

  • 1Turner N,Pearson A,Sharpe Rvet al. FGFR1 amplification drives en-docrine therapy resistance and is a therapeutic target in breast cancer [J]. Cancer Res,2010, 70(5) :2085-2094.
  • 2Weiss J .Sos ML,Seidel D, et al. Frequent and focal FGFR1 am-plification associates with therapeutically tractable FGFR1 de-pendency in squamous cell lung cancer[J]. Sci Transl Med , 2010, 2(62) :62-93.
  • 3Tsimafeyeu I, Demidov L, Stepanova E, et al. Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma[J]. Scand J Urol Nephrol,2011,45(3) :190-195.
  • 4Elbauomy Elsheikh S, Green AR, Lambros MB, et al. FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridi-sation analysis[J]. Breast Cancer Res, 2007 ,9(2) : 23.
  • 5Tenhagen M, van Diest PJ, Ivanova lA, et al. Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets [J]. Endocr Relat Cancer, 2012,19(4):115-129.
  • 6Jang MH, Kim EJ .Choi v, et al. FGFR1 is amplified during the progression of in situ to invasive breast carcinoma [J]. Breast Cancer Res,2012,14(4) :115-127.
  • 7Spears M,Oesterreich Sv Migliaccio I.et al. The p160 ER co-reg-ulators predict outcome in ER negative breast cancer[J]. Breast Cancer Res Treat,2012,131(2): 463-472.
  • 8Tong ZT, Wei JH, Zhang JX, et al. AlB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1[J]. Br J Cancer,2013,108(7) :1470-1479.
  • 9Song JM, Lu M, Liu FF, et al. AlB1 as an independent prognostic marker in hepatocellular carcinoma after hepatic resection[J]. J Gastrointest Surg,2012,16(2) :356-360.
  • 10Torres-Arzayus MI. Zhao J, Bronson R, et al. Estrogen-depend-ent and estrogen-independent mechanisms contribute to AIB1- mediated tumor formation[J]. Cancer Res, 2010,70 (10): 4102- 4111.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部